of baroreceptor-induced changes in heart rate are controversial. According to the classical view (3, 8, lo) , reciprocal changes in cardiac parasympathetic and svmpathetic efferent activity are involved. Newer studies (5), however, suggest that increases in heart rate in response to hypotension are mediated exclusively by increases of sympathetic activity, whereas decreases in heart rate in response to hypertension may be due solely to increases in parasympathetic activity. In another recent study (l), it was concluded that baroreceptor control of heart rate was due primarily to variations in sympathetic efferent discharge, and that changes in parasympathetic tone were less important.
To resolve these differences, experiments were performed in which reflex changes in heart rate were produced in dogs following sympathetic or parasympathetic blockade.
METHODS
In The results of the experiments in which changes in heart rate in response to nitroglycerin-induced hypotension were studied were analyzed separately from those in which changes in heart rate in response to phenylephrine-induced hypertension were investigated. Each set of data was analyzed by analysis of covariance using the maximum changes in heart rate induced by nitroglycerin or phenylephrine as the dependent variable and the associated changes in mean arterial blood pressure as the covariate. Tables  1 and 2 by the time course of the changes in heart rate during stimulation of the carotid sinus nerves. As shown by Warner and Cox (11) stimulation of the sympathetic cardiac efferent nerves produces gradual increase in heart rate which subsides gradually upon discontinuation of stimulation,
In contrast, stimulation of the parasympathetic efferent cardiac nerves produces a prompt decrease in heart rate that returns to the control value quickly upon discontinuation of stimulation. The initial prompt decrease in heart rate during carotid sinus nerve stimulation prior to the administration of atropine is consistent with increased cardiac efferent parasympathetic activity. Following atropine this prompt decrease in heart rate was absent, and a much more gradual decrease in heart rate consistent with decreased cardiac efferent sympathetic activity be- and for mean arterial blood pressure (below) during control period (C) and during administration of nitroglycerin (E) are shown for two groups of dogs before and after administration of propranolol. Left panel shows dogs in which initial heart rate following administration of propranolol was less than 110 beats/min, right panel shows dogs in which control heart rate was higher than 110 beats/min foZlowing administration of propranolol. Note that propranolol abolished increase in heart rate during nitroglycerin-induced hypotension in group of dogs with relatively fast heart rates, but did not do so in groups of dogs with relatively slow heart rates.
came unmasked. These results are in agreement with the findings of similar studies by Wang and Borison (10) Although atropine reduced considerably the tachycardia in response to nitroglycerin-induced hypotension, this was not necessarily related to parasympathetic efferent blockade but may have been due to the fact that the control heart rate under these circumstances was high and probably close to its maximum.
Our results differ from those obtained by Glick and Braunwald (5) mainly because these authors found that pronethalol abolished the tachycardia in response to nitroglycerin-induced hypotension and that pronethalol had no influence on the bradycardia in response to phenylephrineinduced hypertension.
We believe that the major difference between our results and those of Glick and Braunwald (5) is that in most of their animals control heart rates were high, suggesting low resting efferent parasympathetic cardiac tone. Figure 7 shows our data rearranged in such a manner that the response of heart rate to nitroglycerininduced hypotension is shown according to whether the control heart rate following propranolol was less or greater than 110 beats/min.
In the dogs with relatively slow heart rates, propranolol only partially reduced the tachycardia in response to hypotension, while in the dogs with relatively high heart rates the tachycardia was completely abolished. In fact, the paper by Glick and Braunwald (5) contains evidence indicating that in some of their dogs there was decreased cardiac parasympathetic efferent activity in response to nitroglycerin-induced hypotension. In their Fig. 1 which depicts a dog with relatively slow heart rate (approximately 80 beats/min), the control record shows periodic variation in heart rate with a period of 3-4 XC which is almost certainly due to sinus arrhythmia. This periodic variation in heart rate disappeared promptly following the induction of hypotension with nitroglycerin. It is well known that sinus arrhythmia is produced primarily by periodic alterations in parasympathetic efferent cardiac activity (6). Therefore, the disappearance of sinus arrhythmia during nitroglycerin-induced hypotension may be taken as evidence that cardiac efferent parasympathetic activity decreased. It might be argued that increased cardiac efferent sympathetic discharge might have resulted in abolition of sinus arrhythmia. This, however, is not the case, as shown in Fig. 8 , where electrical stimulation of the stellate ganglion had no effect on sinus arrhythmia, although heart rate accelerated by approximately 40 beats/ min. Our findings are in agreement with those of Robinson et al. (7) who showed that in resting man the changes in heart rate induced reflexly by alterations in arterial blood pressure were mediated by reciprocal changes in sympathetic and parasympathetic efferent cardiac activity. These authors also showed that the contribution of altered activity of each branch of the autonomic nervous system to the change in heart rate depended strongly on its control level of activity existing prior to the alteration in blood pressure. This finding may explain some of the divergent results obtained by other investigators. We have no explanation as to why the bradycardia in response to phenylephrine-induced hypertension was reduced by beta-adrenergic receptor blockade in our studies while it was not in the studies of Glick and Braunwald (5). In both our study and in that of Glick and Braunwald (5) the bradycardia in response to phenylephrine-induced hypertension was abolished by atropine (Fig. 2) . However, this result need not be interpreted as indicating that the bradycardia in response to phenylephrine-induced hypertension is solely the result of increased cardiac efferent parasympathetic discharge. Phenylephrine, in the atropinetreated animal, has a positive chronotropic effect. This was evident in some of our animals and in those of Glick and Braunwald (5), and has been noted by other investigators (2, 9). The same effect is also found in the dog with cardiac denervation brought about by cardiac transplantation (unpublished observations). It is likely that this positive chronotropic effect might have counteracted the decrease in heart rate resulting from diminished cardiac efferent sympathetic discharge. It is for this reason that we did not rely exclusively on the phenylephrine-induced changes in heart rate but also studied the responses to carotid sinus nerve stimulation. 
